Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 25.35
-0.83 (-3.17%)
Sep 24, 2026, 3:00 PM CST
SHA:688321 Revenue
Shenzhen Chipscreen Biosciences had revenue of 286.19M CNY in the quarter ending June 30, 2026, with 17.13% growth. This brings the company's revenue in the last twelve months to 1.05B, up 37.29% year-over-year. In the year 2025, Shenzhen Chipscreen Biosciences had annual revenue of 910.06M with 38.32% growth.
Revenue (ttm)
1.05B
Revenue Growth
+37.29%
P/S Ratio
10.71
Revenue / Employee
1.02M
Employees
1,031
Market Cap
11.21B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 910.06M | 252.11M | 38.32% |
| Dec 31, 2024 | 657.95M | 134.24M | 25.63% |
| Dec 31, 2023 | 523.71M | -6.23M | -1.18% |
| Dec 31, 2022 | 529.94M | 99.49M | 23.11% |
| Dec 31, 2021 | 430.45M | 160.98M | 59.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.